Status:
UNKNOWN
Virtual Reality in Aphasia Telerehabilitation
Lead Sponsor:
University of Oulu
Collaborating Sponsors:
Peili Vision Oy
Verve Oulu
Conditions:
Aphasia, Acquired
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The main purpose of this study is to evaluate the use of the immersive 3D HMD VR technology in the language intervention with a home-based telerehabilitation approach for people with aphasia. The asse...
Detailed Description
The purpose of the present project is to study the effects, feasibility, and the participants' experiences of this novel kind of language intervention. The effects of the intervention will be studied ...
Eligibility Criteria
Inclusion
- Post-stroke aphasia ≥ 3 months from stroke
- Age 18-75 years
- Finnish as a native language
- Relative have the motivation and willingness to support person with aphasia in rehabilitation process
- At least some level of spoken output
- Moderate-to-severe aphasia
- Deficit in a word retrieval process
Exclusion
- Participation in other intervention study during the study
- Participation in other traditional speech and language therapy during the VR-intervention (i.e. 9-10 weeks period).
- Severe and current psychotic disorder
- Dementia/other neurodegenerative disease
- History of previous stroke (/strokes) if not recovered, excluding TIAs (the criteria for the recovery: no residual aphasia or other disabilities caused by stroke which would affect in significant manner on everyday life)
- Active epilepsy / migraine (\< 3 years)
- Severe apraxia of speech
- Inability to act according to given instruction
- Severe neuropsychological disorder or the decline of cognitive / memory functions, which would significantly affect for training during the VR-intervention
- Vision or hearing impairment which would prevent the use of VR HMD
- if the participant's treatment or medication is unsuitable with the use of VR HMD device as assessed by the physician
- if the participant has the pacemaker or implantable (electric) medical device
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04828759
Start Date
April 1 2021
End Date
December 31 2025
Last Update
April 2 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.